期刊文献+

美洛昔康与吲哚美辛防治全髋关节置换后异位骨化的比较(英文) 被引量:4

Meloxicam versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty
下载PDF
导出
摘要 背景:为了避免全髋关节置换后发生异位骨化,常使用吲哚美辛等非类固醇类消炎药进行预防治疗。目的:对比观察美洛昔康与吲哚美辛对全髋关节置换后预防异位骨化药物的效果。方法:收集2010至2011年广州中医药大学第一附属医院骨科收治的51例患者,其中9例患者行双侧全髋关节置换,所有患者均由同一位医师采用后外侧入路进行关节置换。根据患者置换后使用的药物不同,分为对照组及实验组,分别在置换后口服吲哚美辛缓释片25 mg/d+奥美拉唑肠溶胶囊20 mg/d或美洛昔康片15 mg/d。结果与结论:单独使用美洛昔康和使用吲哚美辛+奥美拉唑对关节置换患者异位骨化的发生率、疼痛、改良D'Aubigne和Postel评分的差异均无显著性意义(P>0.05),但美洛昔康的胃肠道不良反应较少。因此,认为单独服用美洛昔康能够有效避免异位骨化的发生及缓解疼痛,可以作为预防全髋关节置换后异位骨化及疼痛的推荐用药。 BACKGROUND:In order to avoid heterotopic ossification after total hip arthroplasty, nonsteroidal anti-inflammatory drugs are commonly used for prevention. OBJECTIVE:To compare the effect of meloxicam and indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. METHODS:Fifty-one patients who treated in the Department of Orthopedics, the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine from 2010 to 2011 were col ected. Among the 51 patients, nine patients were treated with bilateral total hip arthroplasty, and al the patients had total hip arthroplasty with the posterior-lateral approach. The patients were divided into the control group and the experimental group according to the drugs used after replacement, and the patients in the two groups were administered with indomethacin sustained-release tablet 25 mg+omeprazole capsule 20 mg or meloxicam tablet 15 mg after replacement. RESULTS AND CONCLUSION:There were no significant differences in the incidence of heterotopic ossification, pain, modified D’Aubigne and Postel scores after replacement between two groups (P〉0.05). But, the gastrointestinal adverse reactions of the experimental group were less than those of the control group. The application of meloxicam only can effectively avoid the heterotopic ossification and release pain. Consequently, we recommend meloxicam as postoperative drug for the prevention of heterotopic ossification and pain remission fol owing total hip arthroplasty.
出处 《中国组织工程研究》 CAS CSCD 2013年第39期6867-6874,共8页 Chinese Journal of Tissue Engineering Research
关键词 骨关节植入物 人工假体 异位骨化 全髋关节置换 美洛昔康 吲哚美辛 Brooker分级 髋关节 arthroplasty, replacement, hip prosthesis implantation anti-inflammatory agents,
  • 相关文献

参考文献2

二级参考文献17

  • 1谭炳毅,贾连顺,王海燕,蔡国栋,董军.应力刺激对于后纵韧带骨化因子的影响[J].中国矫形外科杂志,2006,14(13):1013-1015. 被引量:6
  • 2陈棣,叶伟胜.骨形态发生蛋白的成骨功能及临床应用[J].中华外科杂志,1996,34(10):602-605. 被引量:14
  • 3Ritter MA,Vaughan RB. Ectopic ossification after total hip arthro- plasty. Predisposing factors,frequency,and effect on results. J Bone Joint Surg(Am), 1977,59:345-351.
  • 4Goel A,Sharp DJ. Heterotopic bone formation after hip replacement: the influence of the type of osteoarthritis. J Bone Joint Surg(Br), 1991,73:255-257.
  • 5Eggli S,Woo A. Risk factors for heterotopic ossification in total hip arthroplasty. Arch Orthop Trauma Surg,2001,121:531-535.
  • 6Foster DE, Hunter JR. The direct lateral approach to the hip for arthroplasty. Advantages and complications. Orthopedics, 1987,10 (2) : 274-280.
  • 7Duck H J, Mylod AG Jr. Heterotopic bone in hip arthroplasties. Ce- mented versus noncemented. Clin Orthop Relat Res, 1992,282:145- 153.
  • 8Lieberman IH, Moron E, Hastings DE, et al. Heterotopic ossification after primary cemented and noneemented total hip arthroplasty in patients with osteoarthritis and rheumatoid arthritis. Can J Surg, 1994, 37 : 135-139.
  • 9Nayak KN, Mulliken B, Rorabeck CH, et al. Prevalence of hetero- topic ossification in cemented versus noneemented total hip joint re- placement in patients with osteoarthrosis: a randomized clinical trial. Can J Surg, 1997, 40(5): 368-374.
  • 10Harwin SF. Trochanteric heterotopic ossification after total hip arthroplasty performed using a direct lateral approach. J Arthroplas- ty. 2005,20(4) :467-472.

共引文献5

同被引文献36

  • 1高峰,郝亚波,罗开涛.热敏灸治疗膝骨性关节炎的临床研究[J].中华全科医学,2020,0(1):119-121. 被引量:20
  • 2朱仕文,王满宜,吴新宝,曹奇勇,吴宏华,程学.吲哚美辛预防髋臼骨折术后异位骨化的临床研究[J].中华创伤骨科杂志,2006,8(7):613-616. 被引量:20
  • 3高文君,郑慧娟,叶纯华,王康儿,陈立夏.吲哚美辛栓缓解Ⅲ型前列腺炎患者疼痛症状的初步观察[J].浙江临床医学,2007,9(5):607-608. 被引量:6
  • 4Persson PE, Nilsson OS, Berggren AM. Do non-steroidal anti-in- flammatory drugs cause endoprosthetic loosening? A 10-year fol- low-up of a randomized trial on ibuprofen for prevention of hetero- topic ossification after hip arthroplasty [J]. Acta Orthop, 2005,76: 735-740.
  • 5Brooker AF, Bowerman JW, Robinson RA, et al. Ectopic ossifica- tion following total hip replacement. Incidence and a method of classification [J]. J Bone Joint Surg (Am), 1973, 55:1629-1632.
  • 6Tompkins GS, Jaeobs J J, Kull LR, et al. Primary total hip arthro- plasty with a porous coated aeetabular component. Seven to ten year results [J]. J Bone Joint Surg Am, 1997,79(2):169-176.
  • 7Board TN, Karva A, Board RE, et al.The prophylaxis and treatment of hetemtopic ossification following lower limb arthroplasty [J]. Bone Joint Surg (Br),2007,89(4): 434-440.
  • 8Chemaly O,I-Iebert-Davies J,Rouleau DM.Heterotopic ossification following total hip replacement for acetabular fractures [J]. Bone Joint J,2015,95(1):95-100.
  • 9Geller JA. Wang W. Goyal A. Liabaud B.Clinical significance of heterotopic ossification after metal-on-metal total hip resurfacing [J]. Hip Int, 2014,24(2): 129-135.
  • 10肖鹏,王庆雷,王建儒.全髋关节置换术后异位骨化与吲哚美辛的预防效应:同期非随机随访对照[J].中国组织工程研究与临床康复,2008,12(9):1659-1661. 被引量:9

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部